The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Selective Measurement of Two Lipase Activities in Postheparin Plasma from Normal Subjects and Patients with Hyperlipoproteinemia
Open accessAbstract
An assay has been developed for specific measurement of two different lipase activities in postheparin plasma. Lipoprotein lipase, derived from extrahepatic sources, is measured as protamine-inactivated lipase activity; hepatic lipase activity is protamine-resistant under the conditions of this assay. In 100 normal subjects, both enzyme activities were noted to be related to age and sex. Protamine-resistant lipase, which comprised 46-95% of the total activity, was highest in men over 18. Protamine-inactivated lipase activity was greatest in younger males and was age-correlated in women, doubling between the second and sixth decades. In 12 patients with hyperchylomicronemia, including five previously shown to have familial type I hyperlipoproteinemia, protamine-inactivated lipase activity was markedly reduced, whereas protamine-resistant lipase was below normal in only 1. The results were not due to lack of plasma activator, presence of plasma inhibitor, or diet, and the deficiency was not overcome by increasing the provoking dose of heparin from 10 U to 75 U/kg. Mean values for both lipase activities were not reduced in 32 other patients with hyperchylomicronemia, nine with "floating beta" lipoproteins (type III hyperlipoproteinemia), and 23 with hyperprebetalipoproteinemia (type IV). Mean protamine-resistant lipase activity was below normal in a group of four women with hypothyroidism, in whom protamine-inactivated lipase was not reduced. Both of the lipase activities were capable of hydrolyzing lipid in very low-density lipoproteins, but the relative rate of hydrolysis of chylomicrons by protamine-resistant lipase was markedly limited. These results indicate the importance of distinguishing between lipases of hepatic and extra-hepatic origin in the measurement of postheparin lipolytic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Microdetermination of Long-chain Fatty Acids in Plasma and Tissues
Dole, V. P., & Meinertz, H. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)76920-8 · Cited by 2,200
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Self-citationCLEARING FACTOR, A HEPARIN-ACTIVATED LIPOPROTEIN LIPASE
Korn, E. D. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66011-9 · Cited by 853
A specific apoprotein activator for lipoprotein lipase
LaRosa, J. C., Levy, R. I., Herbert, P., Lux, S. E., & Fredrickson, D. S. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90468-7 · Cited by 668
Self-citationThe Familial Hyperlipoproteinemias
Marion, M. S. (1975) · Cited by 528
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Self-citationFormation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons
Redgrave, T. G. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106255 · Cited by 497
Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107334 · Cited by 484
Cited by
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Grunfeld, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.1045 · Cited by 848
A stable, radioactive substrate emulsion for assay of lipoprotein lipase
Nilsson-Ehle, P., & Schotz, M. C. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41752-3 · Cited by 837
Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II
Breckenridge, W. C., Little, J. A., Steiner, G., Chow, A., & Poapst, M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806082982301 · Cited by 603
Parks, E. J., & Hellerstein, M. K. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.412 · Cited by 530
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Zannis, V. I., Chroni, A., & Krieger, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0030-4 · Cited by 390
Després, J.-P., Couillard, C., Gagnon, J., Bergeron, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1932 · Cited by 386
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
SCHAEFER, E. J., FOSTER, D. M., ZECH, L. A., LINDGREN, F. T., BREWER, H. B., & LEVY, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337
Self-citationWeintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331
“The assay itself is a modification of the method of Krauss (54) as recently described (32, 33).”
MethodLipoprotein abnormalities associated with a familial deficiency of hepatic lipase
BRECKENRIDGE, W., LITTLE, J., ALAUPOVIC, P., WANG, C., KUKSIS, A., KAKIS, G., LINDGREN, F., & GARDINER, G. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90136-8 · Cited by 328
Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids
Harris, W. S., Connor, W. E., Alam, N., & Illingworth, D. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38424-8 · Cited by 321
Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions
Godsland, I. F., Wynn, V., Crook, D., & Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90552-7 · Cited by 322
Packard, C. J., Munro, A., Lorimer, A. R., Gotto, A. M., & Shepherd, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111644 · Cited by 298
Huttunen, J. K., Ehnholm, C., Kinnunen, P. K. J., & Nikkilä, E. A. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90055-8 · Cited by 298
Osborne, J. C., & Brewer, H. B. (1977) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60220-x · Cited by 285
Pykälistö, O. J., Smith, P. H., & Brunzell, J. D. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108185 · Cited by 285
Aging and dyslipidemia: A review of potential mechanisms
Liu, H.-H., & Li, J.-J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.001 · Cited by 274
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Goldberg, I. J., Le, N.-A., Paterniti, J. R., Ginsberg, H. N., Lindgren, F. T., & Brown, W. V. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110717 · Cited by 261
Lipoprotein lipase in diabetes
Taskinen, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030208 · Cited by 259
EISENBERG, S., & LEVY, R. I. (1975) · Advances in Lipid Research · doi:10.1016/b978-0-12-024913-8.50008-4 · Cited by 255
Self-citationHyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics
Haffner, S. M., Fong, D., Hazuda, H. P., Pugh, J. A., & Patterson, J. K. (1988) · Metabolism · doi:10.1016/0026-0495(88)90133-3 · Cited by 254
Moulin, P., Dufour, R., Averna, M., Arca, M., Cefalù, A. B., Noto, D., D'Erasmo, L., Di Costanzo, A., Marçais, C., Alvarez-Sala Walther, L. A., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.814 · Cited by 247
Insulin Action in Adipose Tissue and Muscle in Hypothyroidism
Dimitriadis, G., Mitrou, P., Lambadiari, V., Boutati, E., Maratou, E., Panagiotakos, D. B., Koukkou, E., Tzanela, M., Thalassinos, N., & Raptis, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0478 · Cited by 233
Dreon, D., Fernstrom, H., Campos, H., Blanche, P., Williams, P., & Krauss, R. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.828 · Cited by 170
Self-citationInfluence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise
Grandjean, P. W., Crouse, S. F., & Rohack, J. J. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.472 · Cited by 158
PHENOTYPE STUDY OF APOLIPOPROTEIN E ISOFORMS IN HYPERLIPOPROTEINAEMIC PATIENTS
Ghiselli, G., Zech, L., Gregg, R., Schaefer, E., & Brewer, H. B. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90439-1 · Cited by 93
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Stalenhoef, A. F., Malloy, M. J., Kane, J. P., & Havel, R. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112632 · Cited by 70
Genetic Mutations Affecting Human Lipoprotein Metabolism
Zannis, V. I., & Breslow, J. L. (1985) · Advances in Human Genetics 14 · doi:10.1007/978-1-4615-9400-0_3 · Cited by 65
Preetha, P. P., Devi, V. G., & Rajamohan, T. (2014) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1784-7 · Cited by 17
“Lipoprotein lipase (LPL) activity of the heart was estimated according to the procedure of Krauss et al. (1974).”
Method
Metadata
- Authors
- Krauss, R. M., Levy, R. I., & Fredrickson, D. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1974-11-01
- Volume
- 54
- Issue
- 5
- Pages
- 1107-1124
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2005500043
- Cited by
- 437
- References
- 52
- FWCI
- 28.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.